Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease [18]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 2, 2007, Pages 235-237

  Peritogiannis, Vaios ^a   Goulia, Panagiota ^a   Pappas, Dimitrios ^a   Hyphantis, Thomas ^a   Mavreas, Venetsanos ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; PROGESTERONE; PROLACTIN; SERTRALINE;

ADULT; AMENORRHEA; BLOOD EXAMINATION; CASE REPORT; DEPRESSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GYNECOLOGICAL EXAMINATION; HOSPITALIZATION; HUMAN; HYPERPROLACTINEMIA; LETTER; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; REMISSION; SCHIZOPHRENIA;

ADULT; AMENORRHEA; ANTIPSYCHOTIC AGENTS; DEPRESSION; DRUG INTERACTIONS; FEMALE; HUMANS; HYPERPROLACTINEMIA; POLYCYSTIC OVARY SYNDROME; SCHIZOPHRENIA; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SULPIRIDE;

EID: 34247135071     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000264980.17486.49     Document Type: Letter

References (21)

1. Mortimer AM. How do we choose between atypical antipsychotics? The advantages of amisulpride. Int J Neuropsychopharmacol. 2004;7(suppl 1):21-25.
2. Rein W, Coulouvrat C, Dondey-Nouvel L. Safety profile of amisulpride in short- and long-term use. Acta Psychiatr Scand. 2000;101:23-27.
3. Cooper SJ, Mulholland C, Lynch G, et al. Sertraline in the treatment of depressive symptoms in stable, chronic schizophrenia: a placebo controlled trial (abstract). Schizophr Res. 2000;41:209.
4. Kirli S, Caliskan M. A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia. Schizophr Res. 1998;33:103-111.
5. Gordon C, Whale R, Cowen PJ. Sertraline treatment does not increase plasma prolactin levels in healthy subjects (letter). Psychopharmacology (Berl). 1998;137:201-202.
6. Bronzo MR, Stahl SM. Galactorrhea induced by sertraline (letter). Am J Psychiatry. 1993;8:1269-1270.
7. Lesaca TG. Sertraline and galactorrhea (letter). J Clin Psychopharmacol. 1996;16:333-334.
8. Spigset O, Mjorndal T. The effect of fluvoxamine on serum prolactine and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol. 1997;17:292-297.
9. Damsa C, Bumb A, Bianchi-Demicheli F, et al. "Dopamine- dependent" side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry. 2004;65:1064-1068.
10. Silver H. Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia. Int Clin Psychopharmacol. 2003;18:305-313.
11. Saito M, Yasui-Furukori N, Nakagami T, et al. Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients. J Clin Psychopharmacol. 2005;25:527-532.
12. Kaufman K, Gerner R. Lamotrigine toxicity secondary to sertraline. Seizure. 1998;7:163-165.
13. Coucell A, Spencer C, Benfield P. Amisulpride: a review of its pharmacodynamic and pharmacodynamic properties and therapeutic efficacy in management of schizophrenia. CNS Drugs. 1996;6:237-256.
14. Spina E, Scordo MG, D'Arrigo C. Metabolic drug interactions with new psychotropic agents. Fundam Clin Pharmacol. 2003;17:517-538.
15. Kopecek M, Bares M, Svarc J, et al. Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett. 2004;25(6):419-422.
16. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999;19:67-85.
17. Sareen J, Kirshner A, Lander M, et al. Do antipsychotics ameliorate or exacerbate obsessive compulsive disorder symptoms? A systematic review. J Affect Disord. 2004;82:167-174.
18. Keuneman RJ, Pokos V, Weerasundera R, et al. Antipsychotic treatment in obsessive-compulsive disorder: a literature review. Aust N Z J Psychiatry. 2005;39:336-343.
19. Metin O, Yazici K, Tot S, et al. Amisulpride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. Hum Psychopharmacol Clin Exp. 2003;18:463-467.
20. Siris SG, Bench C. Depression and schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford: Blackwell Publishing; 2003:142-167.
21. Thase ME. What role do atypical antipsychotic drugs have in treatment-resistant depression? J Clin Psychiatry. 2002;63(2):95-103.